LEMBASE (Embase™ Learning Database)
Subject
Coverage• Alternative medicine• Biological science relevant to human

•
•
•
•
•
•
•
•
•
•

medicine• Biochemistry• Biomedical engineering and medical••••

instrumentation
Biotechnology
Clinical and experimental medicine
Drugs
Environmental science

Forensic science
Hospital management
Industrial medicine
Medical devices
Occupational hygiene
Pediatrics
Pharmacy
Pharmacology and drug therapy
Pharmaco-economics
Public healthFile Type

Bibliographic, Learning

Features

Thesaurus

Controlled Term (/CT)

Alerts (SDIs)

None

CAS Registry®
Number IdentifiersPage Images



STN AnaVist™

Keep & Share




SLART




STN Easy

Learning Database

Structures®

®

RecordContent• Bibliographic information• Controlled terms (Emtree drug and medical descriptors)• Drug trade names and their manufacturers• Medical device trade names and manufacturers (1998 to the present)• Approximately 80% of the records include abstracts• CAS Registry Numbers

File Size

21,796 (3/2017)

Coverage

Selected records from 1947-2013

Updates

None

Language

English

Database
Producer

In North America:
Elsevier B.V.
Bibliographic Databases
360 Park Avenue SouthNew York, NY 10010-1710
Phone: 212-989-5800
Fax:
212-633-3990
Email:
usembaseinfo@elsevier.com

In Europe and Rest of World(outside Japan):
Elsevier B.V.
E-products TeamRadarweg 29
Amsterdam 1043 NX
Netherlands
Phone: (+31) 20 485 3911
Fax:(+31) 20 485 2912
Email:
ebd-marketing@elsevier.com

In Japan:
Elsevier B.V.
Bibliographic Databases
1-9-15 Higashi-Azabu
Minato-ku Tokyo 106-0044
Japan
Phone: (+81)-3-5561-5031
Fax:(+81)-3-5561-5046
Email:
jpembaseinfo@elsevier.com

March 2017

2
LEMBASE

SourcesMore than 7,600 journals from about 70 countries (approximately 95% of file)Books, conference proceedings, and reports (approximately 5% of file)

User Aids••••

Clusters• LEARNING
STN Database Clusters information (PDF).

PricingEnter HELP COST at an arrow prompt (=>).

March 2017

Online Helps (HELP DIRECTORY lists all help messages available)
STNGUIDE
Embase Journal List is available at: http://www.embase.com/info/
Emtree Thesaurus (updated three times per year)

3
LEMBASE

Search and Display Field Codes
The fields that allow left truncation are marked with an asterisk (*).
SearchCode

Search Field Name

Display
Codes

Search Examples

Basic Index * (contains single words fromthe title (TI), abstract (AB), controlled
term (CT), chemical name (CN),corporate name (CO), name of product(NP), and gene number (GEN) fields, aswell as CAS Registry Numbers)None(or /BI)S STOMACH ULCER
S 51481-61-9
S FOOD(1W)DRUG ADMINISTR?
S ?SPRAY?

AB, CN, CO,
CT, GEN, NP,
RN, TI

Abstract *

/AB

AB

Accession Number/AN

Author (includes editor) (6)/AU

Chemical Name (Drug or Medical Device
Trade Name) (1,2)
Chemical Name Segment *Clinical Trial Numbers/CN (or /TN)

Controlled Term (contains Medical
Descriptors, Drug Descriptors, including
major terms, and EMTREE codes) (3)/CT

Corporate Name (Manufacturer)(2,4)/CO

Corporate Source (4,6)
Country of Publication (ISO code and text)

/CS
/CY

Digital Object Identifier/DOI (or/FTDOI)/DN/DT(or /TC)/EMLS IMAGING STUD?/AB
S ?PHYSEM?/AB
S 85114254/AN
S 2005469912/AN
S JONES, E A/AUS O REILLY?/AUS TAGAMET/CNS NEMBUTAL/CN (L) LABAZ/COS THIOL/CNSS NCT00004730/NCT
S ISRCTN78047760/NCTS STOMACH ULCER/CT (L) DT/CTS *STOMACH ULCER/CTS LINDANE+ALL/CTS CISPLATIN/CT (L) IT/CTS PANCREAS DISEASE/CT
S ANIMAL EXPERIMENT/CT AND L1
S CALBIOCHEM/COS RESEARCH BIOCHEMICALS/COS UNIV ARIZ?/CSS FRANCE/CY
S JP/CY
S 10.1016/?/DOI
S 46328220/DN
S CONFERENCE/DT
S C/DTS SANDHOFF@UNI-BONN.DE/EML
S SANDHOFF DE/EML
S ED>20041100
S ED.FIR>20130500

DN
DT

S L1 and EDAL>20080100
S L2 AND AB/FA
S 016/FSS CANCER/FSS CLASSIC/FSS MEDLINE/FS
S A02168/GEN
S LANCAO/ISN
S 0388-6107/ISN
S 0444810153/ISN
S J CARD SURG/JTS JOURNAL OF CARDIAC SURGERY/JT
S L1 AND EN/LA
S 20090822/MD
S MARROW/MT
S JAPAN/MLS AMGEN/MO
S 2009/MYED
Not displayed
FS

Document Number
Document Type (code and text)
Email Address (4)

/CNS
/NCT

Entry Date (5,7)
Entry Date First Appeared in Embase or
Embase Alert (EMBAL) (5)Entry Date MEDLINE (5,7)
Field Availability
File Segment (code and text)/ED/ED.FIR

Gene Number
International Standard (Document) Number(ISBN, ISSN, CODEN)

/GEN
/ISN

Journal Title (contains full and abbreviatedtitle)
Language (ISO code and text)
Meeting Date
Meeting Information
Meeting Location
Meeting Organizer
Meeting Year

/JT

/EDAL
/FA
/FS

/LA
/MD
/MT
/ML
/MO
/MY

AN
AU, SO
CN

NCT
CT

CO
CS
CY
FTDOI, DOI

CS, EMLED
ED.FIR, ED

GEN
ISN, SO

JT, JTA, JTF,
SO
LA
MD, SO
MT, SO
ML, SO
MO, SO
MY, SO
March 2017

4
LEMBASE

Search and Display Field Codes (cont’d)SearchCode

Search Field Name
Name of ProductPublication Date (5)Publication Year (5)Publisher
Publisher Item Identifier
Source (contains abbreviated journal title,
publication date, collation information(volume, issue, pagination, and numberof references), meeting information,
ISSN, ISBN, and CODEN)
Summary Language (ISO code and text)
Supplementary Terms *Title *
Update Date (5,8)
Update Date MEDLINE (5,8)

Display
Codes

Search Examples

/NP
/PD
/PY
/PB
/PUI
/SO

S ACUSON 128?/NP
S 20040100-20050600/PD
S 2003-2004/PY
S ELSEVIER IRELAND/PB
S “S 0001-706X(96)00022-8”/PUIS HEMATOL PATHOL/SOS (1011-6788 AND 2004)/SONP
PD, SOPY, SO
PB
PUI
SO

/SL
/ST
/TI
/UP
/UPAL

S L3 AND EN/SLS HIPPOCAMPUS/STS AMINO ACID#/TI
S UP20050119
S L1 and UPAL>20080100

SL
ST
TI
ED
ED

(1) Medical device trade names are available from 1998 to the present.
(2) For data after mid-1998, you can use the (L) operator to link the trade names in /CN to manufacturer names in /CO.
(3) An online thesaurus is available in this field.
(4) Search with implied (S) proximity is available in this field.
(5) Numeric search field that may be searched with numeric operators or ranges.
(6) Use (L) to link AU CS pairs.
(7) ED is the entry date for Elsevier-created Embase records and specifically excludes records from the MEDLINE file segment. EDAL is
used for the entry date of Embase records plus MEDLINE file segment records.
(8) UP is the update date for Elsevier-created Embase records and specifically excludes records from the MEDLINE file segment. UPAL
is used for the update date of Embase records plus MEDLINE file segment records.

Limiting Search Codes
Only an L-number for an answer set created in EMBASE may be limited.
SearchCode (1)

Search Field Name
Animal subject
English language records
Female subject
Human subject
Major descriptor
Male subject/NONHUMAN/ENGLISH/FEMALE/HUMAN/MAJOR/MALE

Search Examples
S L4/NON
S L1/MAJ,ENG (2)S L3/FEM
S L1/HUM
S L1/MAJ (3)S L2/MAL(1) The code may be abbreviated to the first three letters.
(2) An answer set may be limited to more than one subject area.
(3) Major terms may be searched directly in the Controlled Term (/CT) field by preceding the search term with an asterisk,e.g., S *LUNG EMBOLISM/CT.

Super Search Fields
Enter a super search code to execute a search in one or more fields that may contain the desired information.
Super search fields facilitate crossfile and multifile searching. EXPAND may not be used with super search
fields. Use EXPAND with the individual field codes instead.
SearchCode

Search Field Name
Index Terms

March 2017

/IT

FieldsSearched/CT, /ST

Search Examples
S ANIMAL EXPERIMENT/IT

Display
Codes
CT, ST

5
LEMBASE

Controlled Term (/CT) Thesaurus
All relationship codes may be used with both the SEARCH and EXPAND command in the Controlled Term(/CT) thesaurus.
Code
ALL
AUTO (1)
BT
HIE
KT
NOTE
NT
PFT
STD
UF
USE

Content
All associated terms(BT, SELF, QA, TYPE, NTYP, HNTE, RN, EC, UF, NT)
Automatic Relationship(SELF, USE)
Broader Terms(BT, SELF)
Hierarchy (Broader and Narrower Terms)(BT, SELF, NT)
Keyword Terms (multiword phrases containing term)(SELF, KT)
Notes associated with the term
(SELF, NOTE, HNTE, RN, EC)
Narrower Terms(SELF, NT)
Preferred Terms and Synonyms(SELF, USE, UF)Standard (Broader and Narrower Terms)(BT, SELF, NT)
Used For (Synonyms) (Forbidden Terms)(SELF, UF)
Use (Preferred Terms)(SELF, USE)

ExampleE JOINT INJURY+ALL/CT
E LINDANE+ALL/CT
E ARTICULAR TRAUMA+AUTO/CT
E ANEURYSM+BT/CT
E MYOPATHY+HIE/CT
E LYMPHOMA+KT/CT
E VIRILIZATION+NOTE/CTS STOMACH DISEASE+NT/CTS SCLEROTHROMBOSIS+PFT/CTS ALPHA AMYLASE + PFT/CT
E KIDNEY FAILURE+STD/CT
E ASPARAGINE+UF/CT
E ARTICULAR TRAUMA+USE/CT(1) Automatic relationship is SET OFF. When SET REL is ON, the result of EXPAND without any relationship code is the same as
described for AUTO.

Thesaurus Field Descriptors
Code

BT
EC
HNTE (1)KT
NT
NTYP (2)QA
RN
TYPE (3)UF
USE

Description
Self
Broader Term
Enzyme Commission Number
History Note
Keyword Term
Narrower Term
Term Name Type
Subheading abbreviation
CAS Registry Number
Term Type
Used For Term (Synonym)
Use (Preferred) Term

(1) Creation date for Preferred Terms, plus additional history notes. May also include scope notes describing how the Preferred Term isindexed.
(2) Applies to Preferred Terms only. Three possible values: MeSH descriptor, device trade name or drug trade name.
(3) Disease term, drug term device term or medical term.

March 2017

6
LEMBASEDISPLAY and PRINT Formats
Any combination of formats may be used to display or print answers. Multiple codes must be separated by
spaces or commas, e.g., D L1 1-5 BIB ABS; D L1 TI,AU,SO,CS,AB. The fields are displayed in the orderspecified.
Hit-term highlighting is available for all searchable fields. Highlighting must be ON during SEARCH to use the
HIT, HITIND, KWIC, and OCC formats.
FormatContent

ExamplesAB
AN (1)AU
AUPB (2,4)
CN (TN) (1)CO (1)CPCS
CT (1)CY
DN (2)
DOI (FTDOI)DT (TC)
ED (UP)
ED.FIR (1,2)
EML (2)FSFTDOI (2)GEN (1)ISN (2)JT (2)JTA (2)
JTF (2)
LA
MD (2)
ML
MO
MT
MY
NCT
NP (1)PB
PD (2)PUI
PY (2)
RN (1)SL
SO
ST
TI (1)

Abstract
Accession Number
AuthorAuthors in Publication Order
Chemical Name (Drug Trade Name)
Corporate Name (Manufacturer)
Copyright MEDLINE (for unique MEDLINE records only)
Corporate Source
Controlled Term
Country of Publication (ISO names)
Document Number
Digital Object Identifier
Document Type
Entry Date
Entry Date First Appeared in Embase or Embase Alert (EMBAL) includes ED (UP)
Email Address
File Segment
Digital Object Identifier
Gene Number
International Standard (Document) Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Meeting Date
Meeting Location
Meeting Organizer
Meeting Information
Meeting Year
Clinical Trial Numbers
Name of ProductPublisher
Publication Date
Publisher Item Identifier
Publication Year
CAS Registry Number
Summary Language
SourceSupplementary Terms
Title

D AB L4 1-5
D AN 1-15
D AU 5 6 8-10
D AUPBD CN L1
D 1-6 L2 CO
D 1 AN CP
D CS L11
D CT 1-17
D 1-7 CY
D DN
D DOI or D FTDOID DT 4-18 L3
D ED, D UP
D ED.FIR
D EML
D FS 1-2
D DOI
D GEN
D 5,6 ISN
D JT
D JTA
D JTF
D LA 4 6 10
D MD
D ML
D MO
D MT
D MY
D NCT
D NP
D PB
D PD
D PUI
D JT PY
D RN 1-15 L2
D SL 1-5
D 5 L3 SO
D ST
D TI 50-70

ABS
ALL

AB
AN, CP, TI, AU, CS, SO, DOI, PB, PUI, CY, DT, FS, NCT, LA, SL, ED (UP), AB,
CT, ST, RN, CN, NP, CO, GEN
AU, CS (grouped in pairs)
AN, CP, TI, AU, CS, SO, DOI, PB, PUI, CY, DT, FS, NCT, LA, SL, ED (UP)(BIB is the default)AN, compressed bibliographic data
ALL, delimited for post-processing
AB, with text labels
ALL, indented with text labels
BIB, indented with text labels
CT, ST, RN, CN, NP, CO, GEN

D ABS 1-10
D ALL 5-10

AU.CS
BIB
CBIB
DALL
IABS
IALL
IBIB
IND (1)March 2017

D AU.CSD BIB 1-10
D CBIBD DALLD IABSD IALLD IBIBD IND L2 1-10

7
LEMBASEDISPLAY and PRINT Formats (cont’d)FormatContent

Examples

SCAN (1,3)
TRIAL (TRI,
FREE, SAM) (1)

TI, CT, ST, RN, CN, NP, CO, GEN (random display without answer numbers)
TI, CT, ST, RN, CN, NP, CO, GEN

D SCAN
D 1-3 TRIAL

HIT
HITIND (1)KWIC
OCC (1)

Fields containing hit terms
IND
Hit term with 20 words on either side (KeyWord-In-Context)
Number of occurrences of hit terms and fields in which they occur

D HIT 5-10
D HITINDD KWIC 1-3
D OCC 1-6

(1) No online display fee for this format.
(2) Custom display only.
(3) SCAN must be specified on the command line, i.e., D SCAN or DISPLAY SCAN.
(4) If 100 or more authors are provided, only the first 99 are presented followed by et al.

SELECT, ANALYZE, and SORT Fields
The SELECT command is used to create E-numbers containing terms taken from the specified field in ananswer set.
The ANALYZE command is used to create an L-number containing terms taken from the specified field in ananswer set.
The SORT command is used to rearrange the search results in either alphabetic or numeric order of thespecified field(s).
Field Name
Abstract
AuthorAuthors in Publication Order
CAS Registry Number
Chemical Name (Drug Trade Name)
Chemical Name and CAS Registry Number
Citation
Clinical Trial Numbers
CODEN
Controlled Term
Corporate Name (Manufacturer)
Corporate Source
Country of Publication
Document Number
Document Type
Email Address
Entry Date
Entry Date First Appeared in Embase or Embase Alert (EMBAL)
Entry Date for MEDLINE
File Segment
Genbank Number
Gene Number
International Standard Book Number
International Standard (Document) Number
International Standard Serial Number
Journal Title
Journal Title, Abbreviated
Journal Title, Full
Language
Meeting Date

Field CodeANALYZE/
SELECT (1)

AB
AU
AUPB
RN
CN (TN)
NAME
CHEM
CIT
NCT
CODEN
CT
CO
CS
CY
DN
DT
EML
ED
ED.FIREDAL
FS
GENBANK
GEN
ISBN
ISN
ISSN
JT
JTA
JTF
LA
MD

Y
Y
Y (8)
Y (2)
Y
Y (2)
Y (2)
Y (3,4)
Y
N
Y
Y
Y
Y
N
Y
Y
Y
Y
Y
Y
Y (2)
Y
N
Y (5)
N
Y
Y (6)
Y (6)
Y
Y

SORT
N
Y
N
N
Y
N
N
N
Y
Y
N
Y
Y
Y
Y
Y
N
Y
Y
N
Y
N
Y
Y
N
Y
Y
Y
Y
Y
Y
March 2017

8
LEMBASE

SELECT, ANALYZE, and SORT Fields (cont’d)Field Name
Meeting Information
Meeting Location
Meeting Organizer
Meeting Year
Name of ProductOccurrence Count of Hit Terms
Publication Date
Publication Year
Publisher Item Identifier
SourceSummary Language
Supplementary Terms
Title
Trade Name
Treatment CodeUpdate Date
Update Date for MEDLINE

Field CodeANALYZE/
SELECT (1)

SORT

MT
ML
MO
MY
NP
OCC
PD
PY
PUI
SO
SL
ST
TI
TN
TC
UP
UPAL

Y
Y
Y
Y
Y
N
Y
Y
Y
Y (7)
Y
Y
Y (default)
Y
Y
Y
Y

Y
Y
Y
Y
Y
Y
Y
Y
Y
N
Y
N
Y
Y
Y
N
N

(1) HIT may be used to restrict terms extracted to terms that match the search expression used to create the answer set, e.g., SEL HIT
RN.
(2) Appends /BI to the terms created by SELECT.
(3) SELECT HIT and ANALYZE HIT are not valid with this field.
(4) Extracts the first author, publication year, volume, and first page with a truncation symbol appended and /RE appended to the terms
created by SELECT.
(5) Selects or analyzes ISSN, ISBN, and CODEN with /ISN appended to the terms created by SELECT.
(6) Appends /JT to the terms created by SELECT.
(7) Selects or analyzes ISSN, ISBN, and CODEN with /SO appended to the terms created by SELECT.
(8) Appends /AU to the terms created by SELECT.

Sample Records
DISPLAY IALLACCESSION NUMBER:
TITLE:AUTHOR:
CORPORATE SOURCE:

AUTHOR:
CORPORATE SOURCE:
AUTHOR:
CORPORATE SOURCE:

SOURCE:DIGITAL OBJECT ID:
PUBLISHER:
PUBLISHER IDENT.:
COUNTRY:
DOCUMENT TYPE:
FILE SEGMENT:LANGUAGE:
SUMMARY LANGUAGE:
ENTRY DATE:March 20172013392941 LEMBASE
Full-text
The role of anti-smoking legislation on cigarette andalcohol consumption habits in Italy.
Pieroni, Luca (correspondence)
Department of Economics, Finance and Statistics, Universityof Perugia, via Pascoli 20, 06123 Perugia, Italy.
lpieroni@unipg.it
Pieroni, Luca (correspondence)
University of the West of England, United Kingdom.
lpieroni@unipg.it
Chiavarini, Manuela; Minelli, Liliana; Salmasi, Luca
Department of Medical and Surgery Specialities and Public
Health, Division of Public Health, University of Perugia,
via del Giochetto, 06123 Perugia, Italy. lminelli@unipg.it;
luca.salmasi@progetti.unipg.it; chiavarini@inwind.it
Health Policy, (July 2013) Vol. 111, No. 2, pp. 116-126.
Refs: 29
ISSN: 0168-8510; E-ISSN: 1872-6054 CODEN: HEPOEO
10.1016/j.healthpol.2013.04.001
Elsevier Ireland Ltd, P.O. Box 85, Limerick, Ireland.
S 0168-8510(13)00098-5
Ireland
Journal; Article
017
Public Health, Social Medicine and Epidemiology
036
Health Policy, Economics and Management
EnglishEnglishEntered Embase: 2 Jul 2013

9
LEMBASE
Last Updated on Embase: 2 Jul 2013
First Entered Embase or Embase Alert: 3 May 2013
ABSTRACT:The short-term effects of public smoking bans on individual
smoking and drinking habits were investigated in this paper. In 2005, a smoking ban
was introduced in Italy, and we exploited this exogenous variation to measure
the effect on both smoking participation and intensity and the indirect effecton alcohol consumption. Using data from the Everyday Life Aspects survey, forthe period 2001-2007, we show that the introduction of smoke-free legislationin Italy significantly affected smoking behavior. We also document significant
indirect effects on alcohol consumption for the main alcoholic beveragecategories. A robustness analysis is also performed, to test the extent towhich unobservable variables may bias our estimated parameters. Our results
are then used to perform a cost-effectiveness analysis of the anti-smoking
legislation in Italy.  2013.
CONTROLLED TERM:

Medical Descriptors:*alcohol consumption
articlecost effectiveness analysis
femalehealth care policy
human
Italy
male
*smoking ban
SUPPLEMENTARY TERM: Anti-smoking legislation; Cost-effectiveness analysis;
Difference-in-Differences; Regression discontinuity

DISPLAY of a Conference Abstract
AN0050751984 LEMBASE
TI
Abl tyrosine kinase controls phagosomal acidification required for killingof Mycobacterium tuberculosis in human macrophages.
AU
Stenger, S. (correspondence); Bruns, H.; Stegelmann, F.; Dohner, K.; Van
Zandbergen, G.
CS
Medizinische Mikrobiologie und Hygiene Ulm, Germany.
AU
Ficker, J.H.; Wagner, M.
CS
Klinikum Nurnberg Nord, Germany.
SO
Pneumologie, (March 2011) Vol. 65, Supp. SUPPL. 1. Abstract Number: V479.
Meeting Info: 52. Kongress der Deutschen Gesellschaft fur Pneumologie und
Beatmungsmedizin e.V.. Dresden, Germany. 07 Apr 2011-10 Apr 2011
ISSN: 0934-8387
PB
Georg Thieme Verlag.
DT
Journal; Conference; (Conference Abstract)
FS
CONF
LA
EnglishSL
EnglishEDEntered STN: Sep 2012
Last Updated on STN: Sep 2012
AB
The mechanisms that regulate the acidification of intracellular compartments are key
to host defense pathways against intracellular pathogens. Here we demonstrate that Abltyrosine kinase, a master switch for cell growth, cell survival and trafficking oforganelles, controls the acidification of lysosomes and phagosomes. Inhibition of Abltyrosine kinase by imatinib, a molecular targeted therapy used as standard treatment forchronic myeloid leukemia reduced the lysosomal pH in macrophages. This pH-shift wasfunctionally relevant because imatinib increased the activity of the proteolytic enzyme
cathepsin D and limited the growth of the major human pathogen Mycobacterium
tuberculosis. These effects were active in vivo because acidic monocytes were more
readily detectable in the blood of imatinib-treated leukaemia patients than in healthy
controls. Given that inhibition of Abl tyrosine kinase enhances macrophage
antimycobacterial activity, imatinib or similar antagonists have the potential tocomplement conventional drug therapy of multidrug- or extremely drug resistanttuberculosis.

March 2017

10
LEMBASEDISPLAY of a Embase Alert Record
AN2013392941 LEMBASE
Full-text
TI
The role of anti-smoking legislation on cigarette and alcohol consumption
habits in Italy.
AU
Pieroni, Luca (correspondence)CS
Department of Economics, Finance and Statistics, University of Perugia,
via Pascoli 20, 06123 Perugia, Italy. lpieroni@unipg.it
AU
Pieroni, Luca (correspondence)
CS
University of the West of England, United Kingdom. lpieroni@unipg.it
AU
Chiavarini, Manuela; Minelli, Liliana; Salmasi, Luca
CS
Department of Medical and Surgery Specialities and Public Health, Divisionof Public Health, University of Perugia, via del Giochetto, 06123 Perugia,
Italy. lminelli@unipg.it; luca.salmasi@progetti.unipg.it;
chiavarini@inwind.it
SO
Health Policy, (July 2013) Vol. 111, No. 2, pp. 116-126.
Refs: 29
ISSN: 0168-8510; E-ISSN: 1872-6054 CODEN: HEPOEO
PB
Elsevier Ireland Ltd, P.O. Box 85, Limerick, Ireland.
PUI S 0168-8510(13)00098-5
CY
IrelandDT
Journal; Article
FS
017
Public Health, Social Medicine and Epidemiology
036
Health Policy, Economics and Management
LA
EnglishSL
EnglishEDEntered Embase: 2 Jul 2013
Last Updated on Embase: 2 Jul 2013
First Entered Embase or Embase Alert: 3 May 2013

DISPLAY TRIAL
TI
Medication adherence and the associated health-economic impact among
patients with type 2 diabetes mellitus converting to insulin pen therapy:
An analysis of third-party managed care claims data.
CT
Medical Descriptors:
adultarticleattributable risk
billing and claims
confidence interval
cost of illness
data basedevice*drug delivery system
drug dosage form comparison
emergency ward
evaluation
femalehealth care costhealth care planning
health care utilization
health economics
hospital costhuman
hypoglycemia: SI, side effectincidence
information processing
insulin treatment
major clinical study
male
managed care
medical practicemorbidity*non insulin dependent diabetes mellitus: DM, disease management*non insulin dependent diabetes mellitus: DT, drug therapy
March 2017

11
LEMBASE

CT

ST
RN
CN
CO
NP
CO

outpatient care*patient complianceresource allocation
retrospective study
statistical analysis
statistical significancesyringetreatment duration
treatment outcome
United States
Drug Descriptors:*insulin aspart: AE, adverse drug reaction*insulin aspart: AD, drug administration*insulin aspart: DT, drug therapy*insulin aspart: PR, pharmaceutics*insulin aspart: PE, pharmacoeconomics
adherence; cost; diabetes; F1exPen; hypoglycemia; insulin pen; outcomes(insulin aspart) 116094-23-6(1) novolog(1) Novo Nordisk (United States)(1) FlexPen(1) Novo Nordisk (United States)

In North America
CAS
STN North America
P.O. Box 3012
Columbus, Ohio 43210-0012 U.S.A.
CAS Customer Center:Phone: 800-753-4227 (North America)
614-447-3700 (worldwide)Fax:
614-447-3751
Email:
help@cas.org
Internet: www.cas.org

In Europe
FIZ Karlsruhe
STN Europe
P.O. Box 2465
76012 Karlsruhe
Germany
Phone: +49-7247-808-555
Fax:+49-7247-808-259
Email:
helpdesk@fiz-karlsruhe.de
Internet: www.stn-international.com

In Japan
JAICI (Japan Association forInternational Chemical Information)
STN Japan
Nakai Building
6-25-4 Honkomagome, Bunkyo-ku
Tokyo 113-0021, Japan
Phone: +81-3-5978-3601 (Technical Service)+81-3-5978-3621 (Customer Service)
Fax:+81-3-5978-3600
Email:
support@jaici.or.jp (Technical Service)customer@jaici.or.jp (Customer Service)
Internet: www.jaici.or.jp

March 2017